Plasmapheresis in Guillain-Barre syndrome

Peter J Dyck, J. F. Kurtzke

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Regardless of the contribution that plasmapheresis may make in treating Guillain-Barre syndrome, supportive care of the patient is still the most important aspect of treatment. Management of airway and respiratory infection; maintaining fluid and salt balance; safeguarding blood pressure and cardiovascular function; supplying sufficient nourishment; preventing and treating bedsores; dealing with anxiety, anger, and depression; and effective rehabilitation are still essential. Despite our concerns that this trial was unblinded, we ourselves would use plasmapheresis in severely affected and worsening patients with Guillain-Barre syndrome. We would not employ this treatment in patients of lesser severity or in those whose clinical state has improved or has plateaued for more than 1 week.

Original languageEnglish (US)
Pages (from-to)1105-1107
Number of pages3
JournalNeurology
Volume35
Issue number8
StatePublished - 1985

Fingerprint

Guillain-Barre Syndrome
Plasmapheresis
Airway Management
Water-Electrolyte Balance
Pressure Ulcer
Anger
Respiratory Tract Infections
Patient Care
Rehabilitation
Anxiety
Salts
Depression
Blood Pressure
Therapeutics

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Dyck, P. J., & Kurtzke, J. F. (1985). Plasmapheresis in Guillain-Barre syndrome. Neurology, 35(8), 1105-1107.

Plasmapheresis in Guillain-Barre syndrome. / Dyck, Peter J; Kurtzke, J. F.

In: Neurology, Vol. 35, No. 8, 1985, p. 1105-1107.

Research output: Contribution to journalArticle

Dyck, PJ & Kurtzke, JF 1985, 'Plasmapheresis in Guillain-Barre syndrome', Neurology, vol. 35, no. 8, pp. 1105-1107.
Dyck PJ, Kurtzke JF. Plasmapheresis in Guillain-Barre syndrome. Neurology. 1985;35(8):1105-1107.
Dyck, Peter J ; Kurtzke, J. F. / Plasmapheresis in Guillain-Barre syndrome. In: Neurology. 1985 ; Vol. 35, No. 8. pp. 1105-1107.
@article{19b21aa322af4cb5bde9c860e400dee0,
title = "Plasmapheresis in Guillain-Barre syndrome",
abstract = "Regardless of the contribution that plasmapheresis may make in treating Guillain-Barre syndrome, supportive care of the patient is still the most important aspect of treatment. Management of airway and respiratory infection; maintaining fluid and salt balance; safeguarding blood pressure and cardiovascular function; supplying sufficient nourishment; preventing and treating bedsores; dealing with anxiety, anger, and depression; and effective rehabilitation are still essential. Despite our concerns that this trial was unblinded, we ourselves would use plasmapheresis in severely affected and worsening patients with Guillain-Barre syndrome. We would not employ this treatment in patients of lesser severity or in those whose clinical state has improved or has plateaued for more than 1 week.",
author = "Dyck, {Peter J} and Kurtzke, {J. F.}",
year = "1985",
language = "English (US)",
volume = "35",
pages = "1105--1107",
journal = "Neurology",
issn = "0028-3878",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Plasmapheresis in Guillain-Barre syndrome

AU - Dyck, Peter J

AU - Kurtzke, J. F.

PY - 1985

Y1 - 1985

N2 - Regardless of the contribution that plasmapheresis may make in treating Guillain-Barre syndrome, supportive care of the patient is still the most important aspect of treatment. Management of airway and respiratory infection; maintaining fluid and salt balance; safeguarding blood pressure and cardiovascular function; supplying sufficient nourishment; preventing and treating bedsores; dealing with anxiety, anger, and depression; and effective rehabilitation are still essential. Despite our concerns that this trial was unblinded, we ourselves would use plasmapheresis in severely affected and worsening patients with Guillain-Barre syndrome. We would not employ this treatment in patients of lesser severity or in those whose clinical state has improved or has plateaued for more than 1 week.

AB - Regardless of the contribution that plasmapheresis may make in treating Guillain-Barre syndrome, supportive care of the patient is still the most important aspect of treatment. Management of airway and respiratory infection; maintaining fluid and salt balance; safeguarding blood pressure and cardiovascular function; supplying sufficient nourishment; preventing and treating bedsores; dealing with anxiety, anger, and depression; and effective rehabilitation are still essential. Despite our concerns that this trial was unblinded, we ourselves would use plasmapheresis in severely affected and worsening patients with Guillain-Barre syndrome. We would not employ this treatment in patients of lesser severity or in those whose clinical state has improved or has plateaued for more than 1 week.

UR - http://www.scopus.com/inward/record.url?scp=0021877692&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021877692&partnerID=8YFLogxK

M3 - Article

VL - 35

SP - 1105

EP - 1107

JO - Neurology

JF - Neurology

SN - 0028-3878

IS - 8

ER -